NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$17.45 USD
-0.39 (-2.19%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.47 +0.02 (0.11%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | 22.50% |
ABR | 2.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.34 |
Next Year | -1.45 |
EPS (TTM) | -1.58 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 144.01M | 147.81M | 580.68M | 614.30M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 148.00M | 151.80M | 588.60M | 638.00M |
Low Estimate | 139.46M | 141.85M | 570.17M | 599.60M |
Year ago Sales | 127.32M | 133.78M | 509.34M | 580.68M |
Year over Year Growth Est. | 13.11% | 10.49% | 14.01% | 5.79% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.34 | -1.34 | -1.45 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.36 | -0.35 | -1.37 | -1.42 |
High Estimate | -0.29 | -0.27 | -1.26 | -1.31 |
Low Estimate | -0.38 | -0.36 | -1.40 | -1.67 |
Year ago EPS | -0.46 | -0.45 | -1.95 | -1.34 |
Year over Year Growth Est. | 26.09% | 24.44% | 31.28% | -7.76% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 5 | 5 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.34 | -1.34 | -1.45 |
7 Days Ago | -0.34 | -0.34 | -1.34 | -1.45 |
30 Days Ago | -0.34 | -0.34 | -1.34 | -1.45 |
60 Days Ago | -0.41 | -0.42 | -1.59 | -1.69 |
90 Days Ago | -0.41 | -0.42 | -1.59 | -1.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.34 | -1.34 | -1.45 |
Zacks Consensus Estimate | -0.34 | -0.34 | -1.34 | -1.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.36 | -0.45 | -0.46 | NA |
Estimate | -0.40 | -0.43 | -0.53 | -0.52 | NA |
Difference | 0.09 | 0.07 | 0.08 | 0.06 | 0.08 |
Surprise | 22.50% | 16.28% | 15.09% | 11.54% | 16.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more